Multiple host barriers restrict poliovirus trafficking in mice.
RNA viruses such as poliovirus have high mutation rates, and a diverse viral population is likely required for full virulence. We previously identified limitations on poliovirus spread after peripheral injection of mice expressing the human poliovirus receptor (PVR), and we hypothesized that the host interferon response may contribute to the viral bottlenecks. Here, we examined poliovirus population bottlenecks in PVR mice and in PVR mice that lack the interferon alpha/beta receptor (PVR-IFNAR-/-), an important component of innate immunity. To monitor population dynamics, we developed a pool of ten marked polioviruses discriminated by a novel hybridization-based assay. Following intramuscular or intraperitoneal injection of the ten-virus pool, a major bottleneck was observed during transit to the brain in PVR mice, but was absent in PVR-IFNAR-/- mice, suggesting that the interferon response was a determinant of the peripheral site-to-brain bottleneck. Since poliovirus infects humans by the fecal-oral route, we tested whether bottlenecks exist after oral inoculation of PVR-IFNAR-/- mice. Despite the lack of a bottleneck following peripheral injection of PVR-IFNAR-/- mice, we identified major bottlenecks in orally inoculated animals, suggesting physical barriers may contribute to the oral bottlenecks. Interestingly, two of the three major bottlenecks we identified were partially overcome by pre-treating mice with dextran sulfate sodium, which damages the colonic epithelium. Overall, we found that viral trafficking from the gut to other body sites, including the CNS, is a very dynamic, stochastic process. We propose that multiple host barriers and the resulting limited poliovirus population diversity may help explain the rare occurrence of viral CNS invasion and paralytic poliomyelitis. These natural host barriers are likely to play a role in limiting the spread of many microbes.
Kuss
Sharon K
SK
Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Etheredge
Chris A
CA
Pfeiffer
Julie K
JK
D000818:Animals; D001692:Biological Transport; D002490:Central Nervous System / Q000821:virology; D005243:Feces / Q000821:virology; D041981:Gastrointestinal Tract / Q000821:virology; D014644:Genetic Variation; D006801:Humans; D007109:Immunity; D051379:Mice; D008969:Molecular Sequence Data; D017955:Poliovirus / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D053633:Receptor, Interferon alpha-beta / Q000502:physiology*; D011991:Receptors, Virus / Q000502:physiology*; D014774:Virulence; D014779:Virus Replication
D011991:Receptors, Virus; C066100:poliovirus receptor; D053633:Receptor, Interferon alpha-beta